While some urine‐based biomarkers for lupus nephritis, such as urinary T cells, CD163, CD206, or IL‐16 have been defined [5, 6, 7], the diagnosis of lupus nephritis still relies on an invasive kidney biopsy, and none of the investigated biomarkers have been translated into clinical routine. This evidence concerns the gene CD163 and lupus nephritis.